As of 2025-08-10, the Intrinsic Value of Venus Remedies Ltd (VENUSREM.NS) is 331.65 INR. This VENUSREM.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 490.10 INR, the upside of Venus Remedies Ltd is -32.30%.
The range of the Intrinsic Value is 279.49 - 418.39 INR
Based on its market price of 490.10 INR and our intrinsic valuation, Venus Remedies Ltd (VENUSREM.NS) is overvalued by 32.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 279.49 - 418.39 | 331.65 | -32.3% |
| DCF (Growth 10y) | 350.27 - 530.50 | 418.60 | -14.6% |
| DCF (EBITDA 5y) | 526.92 - 785.32 | 652.99 | 33.2% |
| DCF (EBITDA 10y) | 489.71 - 768.08 | 615.62 | 25.6% |
| Fair Value | 847.79 - 847.79 | 847.79 | 72.98% |
| P/E | 650.43 - 765.87 | 687.84 | 40.3% |
| EV/EBITDA | 506.86 - 775.35 | 614.77 | 25.4% |
| EPV | 313.27 - 395.26 | 354.27 | -27.7% |
| DDM - Stable | 150.92 - 324.24 | 237.58 | -51.5% |
| DDM - Multi | 218.19 - 384.79 | 280.34 | -42.8% |
| Market Cap (mil) | 6,552.64 |
| Beta | 1.00 |
| Outstanding shares (mil) | 13.37 |
| Enterprise Value (mil) | 5,768.54 |
| Market risk premium | 8.31% |
| Cost of Equity | 15.57% |
| Cost of Debt | 5.73% |
| WACC | 15.54% |